Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

RICB DIAGNOSTICS AG

History from 24 Jun 2022

UID
CHE-274.461.895
Legal form
AG
Canton
SG
Founded
24 Jun 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 156k
39k78k117k156k28 Oct 2024 · CHF 120k1 Oct 2025 · CHF 140k4 May 2026 · CHF 156k20252026
  • shares

Record

  1. Company formed

    Founded 24 Jun 2022

    SHAB HR01-1005508827 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 119’999.80
    Shares
    1’000’000 → 1’199’998
    New shares, % of post-step shares
    16.7% (199’998 new)
    SHAB HR02-1006164169 ↗
  3. Capital band adopted

    SHAB HR02-1006164169 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    119’999.80 → 139’999.60
    Shares
    1’199’998 → 1’399’996
    New shares, % of post-step shares
    14.3% (199’998 new)
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006446743 ↗
  5. Capital band adopted

    SHAB HR02-1006593080 ↗
  6. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    139’999.60 → 156’082.40
    Shares
    1’399’996 → 1’560’824
    New shares, % of post-step shares
    10.3% (160’828 new)
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006641964 ↗

Published by 8 Oct 2026